Meet with… AbbVie

Oct 10 2013


Program Overview 
Is your company looking for funding? Then join us for a chance to hear from AbbVie, a global biopharmaceutical company whose main focus areas include (but not limited to) immunology, oncology, neuroscience, renal disease, biologics/protein therapeutics and enabling technologies. Don’t miss the opportunity to apply for a one-on-one meeting opportunity with Abbvie!  

Members from the AbbVie team will screen applicants and be in attendance on October 10th to give an overview presentation on their key areas of interest, current portfolio and best practices when starting down the road of funding. Leaders from all areas of the life science industry are encouraged to apply today!


9:30am | Registration & Networking  
10:00am | Presentation   
11:00am | Q&A
11:30am |  Networking Lunch

12:30pm | Optional Tours of Janssen Labs 
12:30-3:30pm | One-on-one Meetings*

*Companies must apply ahead of time and be approved for a one-on-one meeting. The application period ends September 26th. APPLY HERE

About AbbVie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit Follow @abbvie on Twitter or view their Facebook or LinkedIn page.

AbbVie Team
Hamish Allen, Ph.D | Director of Global External Research, AbbVie 
William Kohlbrenner, Ph.D | Director of Global External Research, AbbVie 
Charles Kunsch, Ph.D | Director of Global External Research, AbbVie Labortories
Neela Patel, Ph.D | Director of Global External Research, AbbVie 
Dieter Ziegler, Ph.D. | Director of Global External ResearchAbbVie Deutschland

Program Fees

Presentation & Lunch Only
$25 | General Public 
$35 | General Public Onsite 
Includes presentation, Q&A, lunch and optional tour of Janssen Labs

Presentation Lunch & One-on-One Meeting
It is free to apply, but upon acceptance the following fees will apply: 
$50 | Accepted Companies  
Includes presentation, Q&A, lunch,optional tour of Janssen Labs and one-on-one meeting. Companies must have applied for a one-on-one meeting ahead of time. The application period ends on September 26. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.

Registration to attend the presentation, lunch and optional tours will remain open until October 9th.

NOTE: All companies accepted for a one-on-one meeting will be notified of acceptance by by October 2nd and emailed a specific link to pay the required registration fees online.

About Meet With Series
The purpose of the Meet with Series events sponsored by Janssen Labs is to help start-up entrepreneurs as well as the academic community connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include: Wellcome Trust, MedImmune Ventures, NCI, Mercury Fund and Thomas McNerney & Partners.